151 related articles for article (PubMed ID: 18552406)
1. Immune responses of mice immunized with active recombinant shiga toxin and its derivatives.
Oloomi M; Bouzari S; Ajdary S
Iran J Allergy Asthma Immunol; 2008 Jun; 7(2):53-60. PubMed ID: 18552406
[TBL] [Abstract][Full Text] [Related]
2. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.
Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H
Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497
[TBL] [Abstract][Full Text] [Related]
3. Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.
Ohmura-Hoshino M; Yamamoto M; Yuki Y; Takeda Y; Kiyono H
Vaccine; 2004 Sep; 22(27-28):3751-61. PubMed ID: 15315856
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Shiga toxin B subunit elicits protection against Shiga toxin via mixed Th type immune response in mice.
Gupta P; Singh MK; Singh Y; Gautam V; Kumar S; Kumar O; Dhaked RK
Vaccine; 2011 Oct; 29(45):8094-100. PubMed ID: 21856355
[TBL] [Abstract][Full Text] [Related]
5. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
Wen SX; Teel LD; Judge NA; O'Brien AD
Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
[TBL] [Abstract][Full Text] [Related]
6. Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin.
Tsuji T; Shimizu T; Sasaki K; Shimizu Y; Tsukamoto K; Arimitsu H; Ochi S; Sugiyama S; Taniguchi K; Neri P; Mori H
Vaccine; 2008 Jan; 26(4):469-76. PubMed ID: 18093704
[TBL] [Abstract][Full Text] [Related]
7. Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection.
Cai K; Gao X; Li T; Wang Q; Hou X; Tu W; Xiao L; Tian M; Liu Y; Wang H
Vaccine; 2011 Jan; 29(5):946-52. PubMed ID: 21134452
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a novel Stx2B-Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection.
Gao X; Cai K; Shi J; Liu H; Hou X; Tu W; Xiao L; Wang Q; Wang H
Vaccine; 2009 Mar; 27(14):2070-6. PubMed ID: 19428832
[TBL] [Abstract][Full Text] [Related]
9. Characterization of rabbit polyclonal sera against recombinant Shiga toxin and its subunits for detection of Stx-producing E. coli.
Oloomi M; Bouzari S
Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):41-6. PubMed ID: 21358014
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant effects of cholera toxin b subunit on immune response to recombinant thyrotropin receptor in mice.
Fan JL; Peterson JW; Prabhakar BS
J Autoimmun; 2000 Feb; 14(1):43-52. PubMed ID: 10648115
[TBL] [Abstract][Full Text] [Related]
11. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit.
Marcato P; Mulvey G; Read RJ; Vander Helm K ; Nation PN; Armstrong GD
J Infect Dis; 2001 Feb; 183(3):435-43. PubMed ID: 11133375
[TBL] [Abstract][Full Text] [Related]
12. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia.
Marcato P; Griener TP; Mulvey GL; Armstrong GD
Infect Immun; 2005 Oct; 73(10):6523-9. PubMed ID: 16177326
[TBL] [Abstract][Full Text] [Related]
14. Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli.
Talbot UM; Paton JC; Paton AW
Infect Immun; 2005 Jul; 73(7):4432-6. PubMed ID: 15972544
[TBL] [Abstract][Full Text] [Related]
15. Assessment of immune response of the B subunit of Shiga toxin fused to AAF adhesin of enteroaggregative Escherichia coli.
Oloomi M; Bouzari S
Microb Pathog; 2011; 50(3-4):155-8. PubMed ID: 21238566
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal immunoglobulin a and g against shiga toxin binding subunits produced by intranasal immunization.
Tanikawa T; Ishikawa T; Maekawa T; Kuronane K; Imai Y
Scand J Immunol; 2008 Oct; 68(4):414-22. PubMed ID: 18782271
[TBL] [Abstract][Full Text] [Related]
17. A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2.
Tsuji T; Shimizu T; Sasaki K; Tsukamoto K; Arimitsu H; Ochi S; Shimizu T; Taniguchi K; Noda M; Neri P; Mori H
Vaccine; 2008 Apr; 26(17):2092-9. PubMed ID: 18387720
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunization with a ricin toxin B subunit-rotavirus NSP4 fusion protein stimulates a Th1 lymphocyte response.
Choi NW; Estes MK; Langridge WH
J Biotechnol; 2006 Jan; 121(2):272-83. PubMed ID: 16181698
[TBL] [Abstract][Full Text] [Related]
19. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
20. Bursin as an adjuvant is a potent enhancer of immune response in mice immunized with the JEV subunit vaccine.
Wang C; Wen WY; Su CX; Ge FF; Dang ZG; Duan XG; Cao RB; Zhou B; Chen PY
Vet Immunol Immunopathol; 2008 Apr; 122(3-4):265-74. PubMed ID: 18191231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
